Program outline now available!
The APLAR 2026 official program is scheduled in the South Korea time zone (UTC+9). To check the program times in your location, use a time zone converter.
As more information becomes available – this page will be updated so please make sure to check back regularly.
Program is best viewed on a desktop or large landscape screen.
Congress Travel Grants
APLAR will award 50 need-based travel stipends to AYR members, covering part of their travel and lodging expenses along with complimentary conference registration.
Cell key:
Industry
Main Program
Poster Viewing
Social Function
| Workshop | |
|---|---|
|
0700-0800 |
REGISTRATION |
|
0800-1030 |
|
|
1030-1045 |
BREAK |
|
1045-1230 |
Musculoskeletal Ultrasound Workshop Day 1 (continues) |
|
1230-1330 |
LUNCH |
|
1330-1500 |
Musculoskeletal Ultrasound Workshop Day 1 (continues) |
|
1500-1515 |
BREAK |
|
1515-1745 |
Musculoskeletal Ultrasound Workshop Day 1 (continues) |
| Concurrent | Concurrent | Concurrent | Concurrent | |||
|---|---|---|---|---|---|---|
|
0800
|
REGISTRATION |
|||||
|
0900-1030
|
|
Workshop 2 – GRAPPA Workshop
|
Workshop 3 – Clinical review
|
Workshop 4 – TBC
|
||
|
1030-1045
|
BREAK |
|||||
|
1045-1245
|
Musculoskeletal Ultrasound Workshop Day 2 (continues) |
Workshop 2 – GRAPPA Workshop (continues)
|
Workshop 3 – Clinical review (continues)
|
Workshop 4 – TBC (continues)
|
||
|
1245-1330
|
LUNCH BREAK |
|||||
|
1330-1500
|
Musculoskeletal Ultrasound Workshop Day 2 (continues) |
Workshop 2 – GRAPPA Workshop (continues)
|
Workshop 3 – Clinical review (continues)
|
Workshop 4 – TBC (continues)
|
||
|
1500-1700
|
Pre-congress Industry workshop 1
|
Pre-congress Industry workshop 2
|
Pre-congress Industry workshop 3
|
Pre-congress Industry workshop 4
|
||
|
1700-1800
|
Opening Ceremony Included in registration. View more information here |
|||||
|
1800-1930
|
Welcome Reception and Official Opening of Exhibition Hall Included in registration. View more information here |
|||||
| Plenary / Concurrent 1 | Concurrent 2 | Concurrent 3 | Concurrent 4 | |
|---|---|---|---|---|
|
0700 |
REGISTRATION
|
|||
|
0830-1000
|
Plenary session 1: State-of-the-Art Management of Rheumatic Diseases
Chairpersons: TBC Rheumatoid Arthritis (RA) Tsutomu Takeuchi SLE Mandana Nikpour Osteoporosis Kenneth Saag |
|||
|
1000-1025 |
BREAK |
Poster viewing |
||
|
1025-1125
|
Morning symposium 1
Title coming soon |
Morning symposium 2
Title coming soon |
Morning symposium 3
Title coming soon |
Morning symposium 4
Title coming soon |
|
Sponsored by Celltrion
|
Sponsored by GSK
|
Sponsored by AbbVie
|
Sponsored by Viatris
|
|
|
1125-1130 |
Transition between sessions |
|||
|
1130-1245 |
SIG session
|
SIG session
|
LOC session 1
|
SIG session |
|
1245-1250
|
Transition between sessions |
|||
|
1250-1420 |
|
Lunch symposium 1
Title coming soon |
Lunch symposium 2
|
Lunch symposium 3
|
|
Sponsored by Boehringer Ingelheim
|
||||
|
1420-1425
|
Transition between sessions |
|||
|
1425-1540 |
SIG session |
SIG session
|
LOC session 2
|
Abstract session 1
|
|
1540-1610 |
BREAK |
Poster viewing |
||
|
1610-1725 |
SIG session
|
SIG session |
SIG session
|
SIG session
|
|
1725-1730 |
Transition between sessions
|
|||
|
1730-1825 |
Evening symposium 1
|
Evening symposium 2
|
Evening symposium 3
Title coming soon |
Evening symposium 4
|
|
Sponsored by Chugai Pharmaceutical / JW Pharmaceutical
|
||||
| Plenary / Concurrent 1 | Concurrent 2 | Concurrent 3 | Concurrent 4 | |||
|---|---|---|---|---|---|---|
|
0700 |
REGISTRATION
|
|||||
|
0830-1000
|
Plenary session 2: Translational Research and Artificial Intelligence in Rheumatology
Chairpersons: TBC Understanding rheumatic disease through continuous cell state analysis Soumya Raychaudhuri Artificial intelligence and machine learning in axial spondyloarthritis Denis Poddubnyy Digital healthcare regarding Rheumatic diseases Anindita Santosa |
|||||
|
1000-1025 |
BREAK |
Poster viewing |
||||
|
1025-1125
|
Morning symposium 5
|
Morning symposium 6
|
Morning symposium 7
Title coming soon |
Morning symposium 8
Title coming soon |
||
|
Sponsored by Johnson & Johnson
|
Sponsored by AbbVie
|
Sponsored by Medac
|
||||
|
1125-1130 |
Transition between sessions |
|||||
|
1130-1245 |
SIG session
|
SIG session
|
LOC session 3
|
SIG session |
||
|
1245-1250
|
Transition between sessions |
|||||
|
1250-1420 |
|
Lunch symposium 4
|
Lunch symposium 5
|
Lunch symposium 6
|
||
|
1420-1425
|
Transition between sessions |
|||||
|
1425-1540 |
SIG session
|
SIG session
|
LOC session 4
|
Abstract session 2
|
||
|
1540-1610 |
BREAK |
Poster viewing |
||||
|
1610-1725 |
SIG session
|
SIG session |
LOC session 5
|
Abstract session 3
|
||
|
1725-1730 |
Transition between sessions
|
|||||
|
1730-1825 |
Evening symposium 5
|
Evening symposium 6
|
Evening symposium 7
|
Evening symposium 8
|
||
|
Sponsored by Eisai
|
||||||
|
1900-Late |
Joint Presidential Gala dinner |
|||||
| Plenary / Concurrent 1 | Concurrent 2 | Concurrent 3 | Concurrent 4 | |||
|---|---|---|---|---|---|---|
|
0700 |
REGISTRATION
|
|||||
|
0800-0915 |
SIG session
|
SIG session
|
SIG session
|
SIG session
|
||
|
0915-0920 |
Transition between sessions |
|||||
|
0920-1050
|
Plenary session 3: Enhancing the Quality of Patient Care in Rheumatology
Chairpersons: TBC The Evolution and Prospects of the Collaboration between EULAR and APLAR Xenofon Baraliakos Improving Patient Outcomes through Evidence-based, Multidisciplinary Treatment Rachelle Buchbinder Enhancing Quality of Patient Care in Rheumatoid Arthritis: From Clinic to Research Ho-Youn Kim |
|||||
|
1050-1115 |
BREAK |
Poster viewing |
||||
|
1115-1230
|
SIG session
|
SIG session
|
LOC session 6
|
SIG session |
||
|
1230-1235
|
Transition between sessions |
|||||
|
1235-1405
|
|
|
Lunch symposium 7
|
|
||
|
1405-1410
|
Transition between sessions |
|||||
|
1410-1525
|
SIG session
|
Abstract session 4
|
LOC session 7
|
Abstract session 5
|
||
|
1525-1530 |
Transition between sessions
|
|||||
|
1530-1605 |
Closing ceremony and awards |
|||||
APLAR 2026 Information coming soon
Thank you for your patience as we prepare the necessary information for APLAR 2026.